Johnson & Johnson received U.S. Food and Drug Administration approval for its soft tissue surgical robot, giving the healthcare company a long-sought entry into the surgical robotics market.
Bloomberg reported the robot comes after more than a decade of research and years of delays.
Johnson & Johnson Wins FDA Approval for Soft Tissue Surgical Robot
2026-07-22 11:13:36
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Chile Plans $100 Billion Copper Push to Reach Data Center BuyersNext article：
No next page found
